Palatin Technologies, Inc.
PTN
|
$1.89
-0.53%
0.0%
180K
|
Health Technology
(0.0% 1d) (21.0% 1m) (-27.8% 1y) (0.0% 2d) (0.0% 3d) (4.4% 7d) (-2.68% volume)
Earnings Calendar:
Market Cap: $ 30,498,250
http://www.palatin.com
Sec Filling | Patents | 20 employees
(US) Palatin Technologies, Inc. is a biopharmaceutical company, which engages in the development of medicines based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. Its primary product candidate is marketed under the Vyleesi brand, the trade name for bremelanotide, a peptide melanocortin receptor 4 agonist for the treatment of premenopausal women with acquired, generalized, hypoactive sexual desire disorder (HSDD). The company was founded by Carl Spana and John K. A. Prendergast on November 21, 1986 and is headquartered in Cranbury, NJ.
women brands treatment
Drugs
Vyleesi (bremelanotide)add to watch list Paper trade email alert is off
Press-releases
Palatin Announces Results of PL9643 MELODY-1 Pivotal Phase 3 Clinical Trial in Patients with Dry Eye Disease (DED)
Published: 2024-02-28 (Crawled : 12:30) - prnewswire.com
PTN | $1.89 -0.53% 0.0% 180K
|
Health Technology
|
| O: -44.58%
H: 25.45%
C: 11.36%
pl9643 disease eye trial results
Palatin Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
Published: 2024-02-15 (Crawled : 12:30) - prnewswire.com
PTN | $1.89 -0.53% 0.0% 180K
|
Health Technology
|
| O: -2.66%
H: 0.25%
C: -21.84%
year update financial results
Palatin to Report Second Quarter Fiscal Year 2024 Results; Teleconference and Webcast to be held on February 15, 2024
Published: 2024-02-09 (Crawled : 12:30) - prnewswire.com
PTN | $1.89 -0.53% 0.0% 180K
|
Health Technology
|
| O: 1.24%
H: 4.42%
C: 4.42%
report year
Palatin Announces Database Lock for PL9643 MELODY-1 Pivotal Phase 3 Clinical Trial in Patients with Dry Eye Disease (DED)
Published: 2024-02-05 (Crawled : 12:30) - prnewswire.com
PTN | $1.89 -0.53% 0.0% 180K
|
Health Technology
|
| O: 0.53%
H: 15.53%
C: 7.11%
pl9643 disease eye trial
Palatin Announces Closing of $10 Million Registered Direct Offering
Published: 2024-02-01 (Crawled : 21:00) - prnewswire.com
PTN | $1.89 -0.53% 0.0% 180K
|
Health Technology
|
| O: 8.03%
H: 0.0%
C: -3.08%
million direct offering
Palatin Provides Corporate Update and Highlights Strategic Priorities for Calendar Year 2024
Published: 2024-01-08 (Crawled : 15:30) - prnewswire.com
PTN | $1.89 -0.53% 0.0% 180K
|
Health Technology
|
| O: 1.82%
H: 11.43%
C: 10.71%
year update
Cosette Pharmaceuticals Acquires Vyleesi® (Bremelanotide Injection) from Palatin Technologies Inc.
Published: 2024-01-03 (Crawled : 18:00) - biospace.com/
PTN | $1.89 -0.53% 0.0% 180K
|
Health Technology
|
| O: 0.0%
H: 1.04%
C: -10.62%
vyleesi pharmaceuticals
Palatin Completes Sale of Vyleesi® to Cosette Pharmaceuticals for up to $171 Million
Published: 2023-12-20 (Crawled : 12:30) - prnewswire.com
PTN | $1.89 -0.53% 0.0% 180K
|
Health Technology
|
| O: -4.96%
H: 17.83%
C: 7.39%
vyleesi pharmaceuticals
Palatin Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
Published: 2023-11-14 (Crawled : 12:30) - prnewswire.com
PTN | $1.89 -0.53% 0.0% 180K
|
Health Technology
|
| O: -2.99%
H: 2.56%
C: -1.54%
year update financial results
Palatin to Report First Quarter Fiscal Year 2024 Results; Teleconference and Webcast to be held on November 14, 2023
Published: 2023-11-09 (Crawled : 12:30) - prnewswire.com
PTN | $1.89 -0.53% 0.0% 180K
|
Health Technology
|
| O: 0.0%
H: 2.5%
C: -4.0%
report year
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Last 48 Hours Insiders Buying
AXR P 2400 | $22.17 2.69% 0.0% 5.5K
|
Finance
|
21:00
QCRH P 118 | $55.405 1.33% 1.31% 54K
|
Finance
|
18:01
VUZI P 7500 | $1.26 3.28% 3.17% 1M
|
Electronic Technology
|
18:00
RMCF | $3.61 2.27% 2.22% 18K
|
Consumer Non-Durables
|
20:10